Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: Relation to effectiveness of interferon therapy

Journal of Gastroenterology

Volumn 31, Issue 6, 1996, Pages 806-811

  Fukuda, Ryo ^a   Ishimura, Norihisa ^a   Ishihara, Shunji ^a   Tokuda, Alejandro ^a   Satoh, Shuichi ^a   Sakai, Shino ^a   Akagi, Shuji ^a   Watanabe, Makoto ^a   Fukumoto, Shiro ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; Interferon therapy; Interferon receptor mRNA

Indexed keywords

ALPHA INTERFERON; INTERFERON; MESSENGER RNA; RECEPTOR; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER BIOPSY; LIVER FIBROSIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIVIRAL AGENTS; BIOPSY; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; LIVER; MALE; MIDDLE AGED; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; RNA, MESSENGER; RNA, VIRAL; TREATMENT OUTCOME;

EID: 0030452770     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02358606     Document Type: Article

References (37)

1. Magrin S, Graxi A, Fabiano C, et al. Serum hepatitis C virus (HCV)-RNA and response to alpha interferon in anti-HCV positive chronic hepatitis. J Med Virol 1992;38:200-206.
2. Kanazawa Y, Hayashi N, Mita E, et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994,20:1121-1130
3. Yoshida K, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha. Relationship to genotype of hepatitis C virus. Hepatology 1992;14:35-40.
4. Weiland O, Schvarcz R, Weijstal R, et al. Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alpha-2b: Swedish experience. J Hepatol 1990:11(Suppl 19):S57-S62.
5. Tsubota A, Chayama K, Ikeda K, et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994;19:1088-1094.
6. Enomoto N, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996;334:77-81.
7. Yonehara S, Yonehara-Takahashi M, Ishii A. Binding of human interferon alpha to cells of different sensitivities: Studies with internally radiolabeled interferon retaining full biological activity. J Virol 1983;45:1168-1171
8. Zoon KC, Arnheimer H. Studies of the interferon receptors. Pharmacol Ther 1984,24.259-278.
9. Kato T, Esumi M, Yamashita S, et al Interferon-inducible gene expression in chimpanzee liver infected with hepatitis C virus. Virology 1992;190:856-860.
10. Velazquez L, Fellous M, Stark GR, Pellegrini S. A protein kinase in the interferon alpha/beta signaling pathway. Cell 1992;24:313-322.
11. De Maeyer E, De Maeyer-Guignand J. Interferon receptor. In: De Maeyere E, De Maeyer-Guignand J (eds) Interferon and other revelatory cytokines. New York: John Wiley and Sons, 1988;91-113.
12. Lau AS, Hanningan GE, Freedman MH, Williams BRG. Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy. J Clin Invest 1986; 77:1632-1638.
13. Gallo-Rayet N, Escher E. Adrenocorticotropin receptors in rat adrenal glomerulosa cells. Endocrinology 1985;117:38-46.
14. 125I-labeled human interferon alpha beta and gamma: Comparative receptor-binding data. J Gen Virol 1985;66:1149-1152.
15. Aguet M, Grobke M, Dreiding P. Various human interferon alpha subclasses cross-react with common receptors: Their binding affinities correlate with their specific biological activities. Virology 1984;132:211-216.
16. De Maeyer E, De Maeyer-Guignand J. Production of IFN-γ by T cells and modulation of T cell. B cell, and NK cell activity by interferons. In: De Maeyere E, De Maeyer-Guignand J (eds) Interferon and other revelatory cytokines. New York: John Wiley and Sons, 1988;221-273.
17. Uzé G, Lutfalla G, Gresser I. Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its cDNA. Cell 1990;60:225-234.
18. Ishimura N, Fukuda R, Fukumoto S. Relationship between the expression of interferon-alpha receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases. J Gastroenterol Hepatol 1996;11:712-717.
19. Karino Y, Hige S, Sasaki Y, Tsuyuguchi M, Matsushima T, Miyazaki T, Okuuchi Y, Toyota J Relationship between serum 2-5AS activity and the reduction of HCV-RNA during interferon therapy. In: Nishioka K, Suzuki H, Mishiro S, Oda K (eds). Viral hepatitis and liver disease. Tokyo New York Berlin Heidelberg: Springer, 1994;631-634.
20. Fukuda R, Satoh S, Nguyen TX, et al. Expression of cytokine mRNA in the liver of chronic hepatitis C: Comparison with chronic hepatitis B. J Gastroenterol 1995;31:41-47.
21. Okamoto H, Sugiyama Y, Okada S, et al. Typing of hepatitis C virus by polymerase chain reaction with type specific primers: application to clinical surveys and tracing infectious sources J Gen Virol 1992;73:673-679.
22. Hagiwara H, Hayashi N, Mita E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 1993;104:877-883.
23. Degroote J, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet 1968;11.626-628.
24. Knodell RG, Isak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-435.
25. De Maeyer E, De Maeyer-Guignand J The antiviral activity of interferon. In: De Maeyere E, De Maeyer-Guignand J (eds) Interferon and other revelatory cytokines. New York: John Wiley, Sons, 1988:115-133.
26. Su L, Morgan PR, Harrison DL, Waseen A, Lane EB. Expression of keratin mRNAs and proteins in normal salivary epithelia and pleomorphic adenomas. J Pathol 1993;171:173-181.
27. Greenway AL, Hertzog PJ, Devenish RJ, et al. Immunolocalisation of interferon-alpha in hepatitis C patients and its correlation with response to interferon-alpha therapy. J Hepatol 1994;21:842-852.
28. Müller U, Steihoff U, Reis LF, et al. Functional roles of type I and type II interferons in antiviral defense. Science 1994;264:1918-1921.
29. Branca AA, Bagloni C. Down-regulation of the interferon receptor. J Biol Chem 1982;257:13197-13200.
30. Evans T, Secher DD. Kinetics of internalization and degradation of surface-bound interferon in human lymphoblastoid cells. EMBO J 1984;3:2975-2978.
31. Novick D, Cohen B, Rubinstein M. The human interferon α/β receptor: Characterization and molecular cloning. Cell 1994; 77:391-400.
32. Affabris E, Romeo G, Belardelli F, et al. 2-5A synthetase activity does not increase in interferon-resistant Friend leukemia cell variants treated with α/β interferon despite the presence of high-affinity interferon receptor sites. Virology 1983;125:508-512.
33. 125I-labeled mouse interferon to interferon-resistant embryonal carcinoma cells in vitro. Virology 1981;114:585-588.
34. Klippel JH, Carrete S, Preble S, et al. Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus. Ann Rheum Dis 1985;44:104-108.
35. Koziel MJ, Duddley D, Wong JT, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992;149:3339-3344.
36. Kita H, Moriyama T, Kaneko T, et al. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 1993;18:1039-1044.
37. Lörh HF, Schlaak JF, Gerken G, et al. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994;14:161-166.